BillionToOne's Pioneering Study Demonstrates 100% Accuracy for Non-Invasive Fetal RhD Detection in US Population
- BillionToOne announced a study demonstrating 100% accuracy in its non-invasive prenatal test for fetal RhD status in the U.S. Population.
- The study showed that 100% of 401 pregnancies tested had accurate results, reflecting true clinical performance compared to neonatal RhD serology.
- Dr. Julio Mateus Nino stated that the test allows for avoiding unnecessary RhoGAM administration in about 40% of RhD-negative pregnancies.
- Jennifer Hoskovec highlighted that this technology represents a significant advancement in prenatal care for diverse populations.
Insights by Ground AI
Does this summary seem wrong?
13 Articles
13 Articles
All
Left
1
Center
7
Right
Coverage Details
Total News Sources13
Leaning Left1Leaning Right0Center7Last UpdatedBias Distribution88% Center
Bias Distribution
- 88% of the sources are Center
88% Center
13%
C 88%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage